As of 18 Sept 2026, Zim Laboratories Ltd share price is ₹137.75. The stock opened at ₹137.75 and had closed at ₹136.55 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹59.72 and a high of ₹144.85. In terms of performance, Zim Laboratories Ltd share price has increased by 102.18% over the past six months and has increased by 80.45% over the last year.
ZIMLAB Stock Price Chart
Zim Laboratories Ltd Overview
About ZIMLAB
Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Company has wholly owned subsidiaries (ZIM Laboratories FZE,UAE , SIA ZIM Laboratories Limited, Latvia, ZIM Health Technologies Limited, India and ZIM Thinorals Private Limited, India), subsidiary (ZIMTAS PTY Limited, Australia) and stepdown subsidiary (ZIM Scientific Office L.L.C,UAE (the Company and its subsidiaries are together referred to as 'the Group') which are engaged in manufacturing & wholesale of pharmaceutical products, market research and research & development activities.
Zim Laboratories Ltd Historical Performance
Zim Laboratories Ltd Fundamentals
Zim Laboratories Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 381.87 | 381.26 | 370.16 | 402.96 | 334.00 |
| EBITDA | 40.97 | 48.89 | 44.79 | 57.63 | 42.45 |
| Net Profit | 5.97 | 11.74 | 16.76 | 25.01 | 13.01 |
| EPS | 1.22 | 2.41 | 3.44 | 5.13 | 8.01 |
Zim Laboratories Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 130.67 |
| Resistance 1 (R1) | 140.17 |
| Pivot Point | 134.28 |
ZIMLAB Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Anwar Daud | Chairman |
| Zulfiquar Kamal | Whole Time Director |
| Niraj Dhadiwal | E D & Wholetime Directorector |
Zim Laboratories Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Zim Laboratories Ltd today is ₹137.75 on NSE and ₹137.75 on BSE.
- The 52-week high of Zim Laboratories Ltd is ₹144.85, while the 52-week low is ₹59.72.
- The current market capitalisation of Zim Laboratories Ltd is approximately ₹733 crore.
- The P/E (Price-to-Earnings) ratio of Zim Laboratories Ltd is 52.08. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Zim Laboratories Ltd is 1.27. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Zim Laboratories Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ZIMLAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Zim Laboratories Ltd has delivered a return of approximately 15.67%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Zim Laboratories Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 30.36% promoters, -1.04% FIIs, 1.33% DIIs, and 31.82% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
